清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Peceleganan Spray for the Treatment of Skin Wound Infections: A Randomized Clinical Trial

医学 磺胺嘧啶银 随机对照试验 不利影响 临床试验 临床疗效 内科学 抗菌剂 外科 伤口愈合 有机化学 化学
作者
Yating Wei,Yi Li,Xiaojian Li,Yaohua Zhao,Junci Xu,Haitao Wang,Xinzhou Rong,Junlin Xiong,Xiaodong Chen,Gaoxing Luo,Guozhong Lv,Lin Cai,Chunmao Han,Hongliang Yu,Yi Zhang,Shijie Tang,Youfen Fan,Jiajin Tu,Chengde Xia,Hongxu Zu
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (6): e2415310-e2415310 被引量:21
标识
DOI:10.1001/jamanetworkopen.2024.15310
摘要

Importance: Peceleganan spray is a novel topical antimicrobial agent targeted for the treatment of skin wound infections. However, its efficacy and safety remain unclear. Objective: To assess the safety and efficacy of peceleganan spray for the treatment of wound infections. Design, Setting, and Participants: This multicenter, open-label, phase 3 randomized clinical trial recruited and followed up 570 adult patients diagnosed with secondary open wound infections from 37 hospitals in China from August 23, 2021, to July 16, 2022. Interventions: Patients were randomized to 2 groups with a 2:1 allocation. One group received treatment with 2% peceleganan spray (n = 381) and the other with 1% silver sulfadiazine (SSD) cream (n = 189). Main Outcomes and Measures: The primary efficacy outcome was the clinical efficacy rate (the number of patients fulfilling the criteria for efficacy of the number of patients receiving the treatment) on the first day following the end of treatment (day 8). The secondary outcomes included the clinical efficacy rate on day 5 and the bacterial clearance rate (cases achieving negative bacteria cultures after treatment of all cases with positive bacteria cultures before treatment) on days 5 and 8. The safety outcomes included patients' vital signs, physical examination results, electrocardiographic findings, blood test results, and adverse reactions. Results: Among the 570 patients randomized to 1 of the 2 groups, 375 (98.4%) in the 2% peceleganan treatment group and 183 (96.8%) in the 1% SSD control group completed the trial (n = 558). Of these, 361 (64.7%) were men, and the mean (SD) age was 48.6 (15.3) years. The demographic characteristics were similar between groups. On day 8, clinical efficacy was achieved by 339 patients (90.4%) in the treatment group and 144 (78.7%) in the control group (P < .001). On day 5, clinical efficacy was achieved by 222 patients (59.2%) in the treatment group and 90 (49.2%) in the control group (P = .03). On day 8, bacterial clearance was achieved by 80 of 334 patients (24.0%) in the treatment group and in 75 of 163 (46.0%) in the control group (P < .001). On day 5, bacterial clearance was achieved by 55 of 334 patients (16.5%) in the treatment group and 50 of 163 (30.7%) in the control group (P < .001). The adverse events related to the application of peceleganan spray and SSD cream were similar. Conclusions and Relevance: This randomized clinical trial found that peceleganan spray is a safe topical antimicrobial agent with a satisfactory clinical efficacy rate for the treatment of skin wound infections, while the effectiveness of bacterial clearance remains uncertain. Trial Registration: Chinese Clinical Trial Registry Identifier: ChiCTR2100047202.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
纯情的阁发布了新的文献求助30
刚刚
纯情的阁发布了新的文献求助10
4秒前
4秒前
纯情的阁发布了新的文献求助10
6秒前
6秒前
缥缈的鸡翅完成签到,获得积分10
9秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
14秒前
14秒前
故意的冷安完成签到,获得积分10
16秒前
21秒前
坚定的咖啡完成签到,获得积分10
21秒前
冷艳千柳完成签到,获得积分10
21秒前
24秒前
40秒前
40秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
41秒前
科研通AI6.4的应助被纯情的阁采纳,获得30
41秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
41秒前
池雨完成签到 ,获得积分10
56秒前
苗条的香萱完成签到,获得积分10
1分钟前
年轻狗完成签到,获得积分10
1分钟前
1分钟前
1分钟前
研友_nqrKQZ发布了新的文献求助10
1分钟前
隐形曼青的应助被研友_nqrKQZ采纳,获得10
1分钟前
1分钟前
爱听歌的语堂完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
搞怪山河完成签到,获得积分10
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
星辰大海的应助被天熙采纳,获得10
1分钟前
纯情的阁发布了新的文献求助30
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158905
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719373
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370